11.07.25 -- An Updated View Of The Federal Segment: Access Levers For Manufacturers

Prescription Drug Affordability Boards (PDABs) must clearly define goals, improve data analysis, and boost patient engagement to deliver on the promise of lower-cost medicines.

Trauma shapes how families engage with clinical trials, influencing adherence, decision-making, and data quality. Explore how a patient-centered, empathetic approach is essential to build trust.

The global vaccine clinical trials landscape presents unprecedented opportunities. This report analyses emerging trends, regional opportunities, and Australia’s distinctive strengths in vaccine development.

Achieve greater agility and resilience in biopharma operations by implementing strategic resource optimization, which can generate millions in savings by reducing waste and maximizing the value of existing assets.

Though rescue studies are common, there are ample tactics to avoid these situations altogether, including robust planning, data analysis, and prioritization of patient recruitment and retention.

Review the challenges of cell line development (CLD) in biologics commercialization, and discover how integrated solutions can streamline your strategy, reduce risks, and optimize outcomes.